相关实验视频

Updated: Sep 14, 2025

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists

Published on: November 15, 2013

解读17-β-基类固醇脱酶4:从分子洞察到癌症治疗方法

Meng-Bin Liao^1,2, Andy T Y Lau^3,2, Yan-Ming Xu^4,5

¹The First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, Guangdong, People's Republic of China.

Cancer cell international

|July 19, 2025

概括

17β-基类固醇脱酶4 (HSD17B4) 对于脂质和激素代谢至关重要. 这篇评论探讨了HSD17B4的情况.

科学领域:

生物化学生化学
分子生物学分子生物学
在瘤学瘤学.

背景情况:

17β-基类固醇脱酶4 (HSD17B4) 是一种调节类固醇,脂肪酸和激素代谢的过氧体氧降解酶.
改变的脂质代谢是癌症的标志,影响了癌症的扩散,生存,侵袭和转移.
HSD17B4在癌症中的作用是显著的,但尽管它参与了关键的代谢途径,但仍未得到充分研究.

研究的目的:

审查当前关于人类HSD17B4.4的文献.
讨论将HSD17B4与癌症进展联系起来的分子机制.
突出HSD17B4作为治疗标和在瘤学中的预后生物标记物的潜力.

主要方法:

在人类癌症中对HSD17B4的最新研究的文献综述.
对HSD17B4.4的遗传 (多态,甲基化) 和翻译后 (乙化) 修饰的分析.
综合关于HSD17B4对癌细胞行为和治疗反应的影响的研究结果.

主要成果:

HSD17B4通过其在脂质和激素代谢中的作用,影响癌症的进展.
对HSD17B4的遗传和表观遗传改变会影响其在瘤中的表达和功能.
HSD17B4显示出作为癌症预后的生物标志物和新型治疗的目标的潜力.

结论:

HSD17B4是癌症代谢的关键参与者,具有重要的临床影响.
针对HSD17B4可能为各种癌症提供新的治疗策略.
对HSD17B4的功能和调节进行进一步的研究是为其临床应用的必要.

关键词:

生物标志物生物标志物癌症预后癌症预后药物敏感性药物敏感性表观遗传调节表观遗传调节遗传调节遗传调节遗传调节这就是HSD17B4的原因.翻译后修改 (PTM) 是一种方法.治疗目标治疗目标

更多相关视频

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Fluorescence-based Monitoring of PAD4 Activity via a Pro-fluorescence Substrate Analog

Published on: November 5, 2014

相关概念视频

Transducer Mechanism: Nuclear Receptors

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...